Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Financials · Finance Services

David Bailey to acquire Kindly MD, Inc.

Announced May 12, 2025 · Closed Aug 15, 2025

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
David Bailey
Target
Kindly MD, Inc. (NAKA)
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Aug 15, 2025

Deal protections

Break fee (target pays)
$2.5M
Reverse fee (buyer pays)
$2.5M
Go-shop
—
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Cohen & Company Capital Markets

Sector context · Financials

Comparable deals
60 in the prior 24 months
Premium
Sector median 34.5%
EV / Adj. EBITDA
Sector median 12.5x
Break fee
Sector median 3.7%

Timeline

  1. AnnouncedMay 12, 2025
  2. ClosedAug 15, 2025
Sources
  • 8-K (EX-99.1) · May 12, 2025

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.